Daurismo® (glasdegib)
for Leukemia

Daurismo (glasdegib) is a hedgehog pathway inhibitor that blocks a protein signaling cancer cell growth, helping slow or stop their spread. It’s used with cytarabine as initial treatment for acute myeloid leukemia (AML) in patients over 75 or adults unable to receive other chemotherapy due to health conditions.

Heart
Other top medicines used to treat Leukemia